Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Intra-Cellular Therapies, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ITCI is no longer listed, and 13F filings after Q1 2025 list far fewer holders. See Q1 2025
- Institutional holders
- 4
- −389 vs. Q1 2025
- Shares held
- 52.8K
- −102.6M (−99.9%) vs. Q1 2025
- Total value
- $4.15M
- −$13.5B (−100.0%) vs. Q1 2025
- New holders
- 0
- 0 more added
- Sold out
- 389
- 2 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $2.54K |
| Q1 2026 | 1 | $2.54K |
| Q4 2025 | 1 | $2.54K |
| Q3 2025 | 1 | $2.54K |
| Q2 2025 | 4 | $4.15M |
| Q1 2025 | 395 | $13.6B |
| Q4 2024 | 387 | $8.08B |
| Q3 2024 | 356 | $7.12B |
| Q2 2024 | 376 | $6.62B |
| Q1 2024 | 346 | $6.15B |
| Q4 2023 | 335 | $6.42B |
| Q3 2023 | 294 | $4.54B |
| Q2 2023 | 288 | $5.34B |
| Q1 2023 | 274 | $4.55B |
| Q4 2022 | 283 | $4.41B |
| Q3 2022 | 274 | $3.89B |
| Q2 2022 | 266 | $4.65B |
| Q1 2022 | 241 | $4.94B |
| Q4 2021 | 208 | $3.60B |
| Q3 2021 | 181 | $2.56B |
| Q2 2021 | 187 | $2.74B |
| Q1 2021 | 170 | $2.30B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 51,997 | $4.09M | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 797 | $60.1K | 0.00% | −221−21.7% | Reduced |
| Kestra Investment Management, LLC | 44 | $5.80K | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 1 | $2.54K | 0.00% | −243−99.6% | Reduced |
| Vanguard Group Inc | 0 | $0 | 0.00% | −9,519,968−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −8,754,966−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −5,190,000−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −4,385,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −3,579,571−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −3,485,058−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −3,091,133−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −3,055,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,662,273−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −2,257,912−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,237,131−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,831,951−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,815,287−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −1,781,316−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −1,640,029−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,590,345−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −1,579,685−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,473,764−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,403,399−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −1,093,738−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −1,057,892−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −931,330−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −923,809−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −895,664−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −863,134−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −844,073−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −786,358−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −759,991−100.0% | Sold out |
| Omni Event Management Ltd | 0 | $0 | 0.00% | −750,571−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −719,552−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −719,500−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −700,904−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −693,427−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −691,280−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −663,916−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −634,535−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −625,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −621,815−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −621,200−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −620,699−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −606,808−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −568,000−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −561,266−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −541,642−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −507,200−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −460,267−100.0% | Sold out |
| Taconic Capital Advisors LP | 0 | $0 | 0.00% | −443,700−100.0% | Sold out |
| Twin Securities, Inc. | 0 | $0 | 0.00% | −440,690−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −440,668−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −435,715−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −423,171−100.0% | Sold out |
| Melqart Asset Management (UK) Ltd | 0 | $0 | 0.00% | −400,695−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −382,233−100.0% | Sold out |
| Governors Lane LP | 0 | $0 | 0.00% | −377,737−100.0% | Sold out |
| ING Groep NV | 0 | $0 | 0.00% | −376,800−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −365,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −350,044−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −325,700−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −324,020−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −318,782−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −304,125−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −301,923−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −298,391−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −284,371−100.0% | Sold out |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −275,001−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −268,000−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −266,327−100.0% | Sold out |
| Syquant Capital SAS | 0 | $0 | 0.00% | −266,228−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −255,661−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −253,660−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −253,193−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −252,316−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −247,848−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −240,601−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −229,788−100.0% | Sold out |
| PSquared Asset Management AG | 0 | $0 | 0.00% | −229,086−100.0% | Sold out |
| Empyrean Capital Partners, LP | 0 | $0 | 0.00% | −228,000−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −225,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −220,000−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −219,719−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −214,783−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −202,695−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −202,300−100.0% | Sold out |
| One68 Global Capital, LLC | 0 | $0 | 0.00% | −197,329−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −193,891−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −190,370−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −185,200−100.0% | Sold out |
| Oddo BHF Asset Management SAS | 0 | $0 | 0.00% | −183,100−100.0% | Sold out |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −176,500−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −173,001−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −165,377−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −163,937−100.0% | Sold out |
| St. Louis Trust Co | 0 | $0 | 0.00% | −163,488−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −163,290−100.0% | Sold out |
| Credit Industriel Et Commercial | 0 | $0 | 0.00% | −162,062−100.0% | Sold out |